S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
US joins in other nations in swearing off coal power to clean the climate
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
New CBOE “special perk” helps traders target income every weekend (Ad)
At COP28 meeting, oil companies pledge to combat methane. Environmentalists call it a "smokescreen"
BMW recalls SUVs after Takata air bag inflator blows apart, hurling shrapnel and injuring driver
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
US joins in other nations in swearing off coal power to clean the climate
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
New CBOE “special perk” helps traders target income every weekend (Ad)
At COP28 meeting, oil companies pledge to combat methane. Environmentalists call it a "smokescreen"
BMW recalls SUVs after Takata air bag inflator blows apart, hurling shrapnel and injuring driver
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
US joins in other nations in swearing off coal power to clean the climate
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
New CBOE “special perk” helps traders target income every weekend (Ad)
At COP28 meeting, oil companies pledge to combat methane. Environmentalists call it a "smokescreen"
BMW recalls SUVs after Takata air bag inflator blows apart, hurling shrapnel and injuring driver
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
MarketBeat Week in Review – 11/27 - 12/1
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
US joins in other nations in swearing off coal power to clean the climate
US targets oil and natural gas industry's role in global warming with new rule on methane emissions
New CBOE “special perk” helps traders target income every weekend (Ad)
At COP28 meeting, oil companies pledge to combat methane. Environmentalists call it a "smokescreen"
BMW recalls SUVs after Takata air bag inflator blows apart, hurling shrapnel and injuring driver

Conformis Stock Price, News & Analysis (NASDAQ:CFMS)

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$2.25
▼
$2.27
50-Day Range
$2.22
▼
$2.26
52-Week Range
$1.05
▼
$7.25
Volume
7,000 shs
Average Volume
99,585 shs
Market Capitalization
$17.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media

CFMS stock logo

About Conformis Stock (NASDAQ:CFMS)

Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, iTotal CR, and iTotal PS, as well as provides iTotal Identity and Identity Imprint knee replacement products. It also offers Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, Brazil, the United Arab Emirates, the Sultanate of Oman, Italy, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.


CFMS Stock News Headlines

October 10, 2023 | investing.com
Computer Forms (Malaysia) Bhd (CFMS)
September 6, 2023 | bizjournals.com
Struggling medical device firm Conformis acquired by Duke spinout
December 3, 2023 | DTI Trader (Ad)
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
September 5, 2023 | bizjournals.com
Durham medtech completes acquisition of public company
August 23, 2023 | finance.yahoo.com
Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Conformis Stockholders Vote “FOR” the Pending Merger with restor3d
August 22, 2023 | finanznachrichten.de
Conformis, Inc.: Independent Proxy Advisory Firm ISS Recommends Conformis Stockholders Vote "FOR" the Pending Merger with restor3d
August 21, 2023 | finance.yahoo.com
Independent Proxy Advisory Firm ISS Recommends Conformis Stockholders Vote “FOR” the Pending Merger with restor3d
August 10, 2023 | markets.businessinsider.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HCCI, EQRX, CFMS
December 3, 2023 | DTI Trader (Ad)
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
July 20, 2023 | finance.yahoo.com
There's No Escaping Conformis, Inc.'s (NASDAQ:CFMS) Muted Revenues Despite A 86% Share Price Rise
June 26, 2023 | bizjournals.com
Small medtech startup from Durham to buy $58M public company in cash deal
June 26, 2023 | bizjournals.com
Durham medtech to buy $58M public company
June 24, 2023 | benzinga.com
Conformis Stock (NASDAQ:CFMS), Insider Trading Activity
June 23, 2023 | benzinga.com
Shareholder Alert: Ademi LLP investigates whether Conformis, Inc. has obtained a Fair Price in its transaction with restor3d
June 23, 2023 | benzinga.com
CFMS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Conformis, Inc. Is Fair to Shareholders
June 23, 2023 | bizjournals.com
Conformis stock nearly doubles on acquisition news
June 23, 2023 | finanznachrichten.de
Conformis, Inc.: Conformis Announces Definitive Agreement to be Acquired by restor3d for a Purchase Price of $2.27 Per Share in Cash
June 23, 2023 | nasdaq.com
Restor3d To Acquire Conformis For $2.27/shr In Cash
June 23, 2023 | benzinga.com
Why Conformis Stock Is Shooting Higher Today
June 23, 2023 | finance.yahoo.com
Conformis Announces Definitive Agreement to be Acquired by restor3d for a Purchase Price of $2.27 Per Share in Cash
May 10, 2023 | finanznachrichten.de
Conformis, Inc.: Conformis Reports First Quarter 2023 Financial Results
May 10, 2023 | msn.com
ConforMIS beats Q1 top and bottom line estimates; initiates Q2 outlook
May 10, 2023 | yahoo.com
Conformis Reports First Quarter 2023 Financial Results
May 10, 2023 | finance.yahoo.com
Conformis, Inc. (NASDAQ:CFMS) Q1 2023 Earnings Call Transcript
April 13, 2023 | finance.yahoo.com
Conformis, Inc. to Announce Financial Results for Its First Quarter on May 8, 2023
March 21, 2023 | finance.yahoo.com
Conformis Launches Patient Awareness Campaign to Highlight the Benefits of Personalized Knee Replacement Procedures
March 7, 2023 | insidermonkey.com
Conformis, Inc. (NASDAQ:CFMS) Q4 2022 Earnings Call Transcript
See More Headlines
Receive CFMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Conformis and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/03/2021
Today
12/02/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Medical Devices
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CFMS
CUSIP
N/A
CIK
1305773
Web
www.conformis.com
Phone
(781) 345-9001
Fax
781-345-0147
Employees
295
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($5.61)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-50,470,000.00
Net Margins
-72.72%
Pretax Margin
-72.63%
Return on Equity
-86.46%
Return on Assets
-47.65%

Debt

Debt-to-Equity Ratio
0.64
Current Ratio
5.07
Quick Ratio
3.30

Sales & Book Value

Annual Sales
$57.06 million
Price / Sales
0.31
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.07 per share
Price / Book
0.56

Miscellaneous

Outstanding Shares
7,878,000
Free Float
7,579,000
Market Cap
$17.80 million
Optionable
Not Optionable
Beta
1.39
5G Stocks: The Path Forward is Profitable Cover
5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Mark A. AugustiMr. Mark A. Augusti (Age 57)
    CEO, Pres & Director
    Comp: $1.02M
  • Ms. Denise E. Pedulla J.D. (Age 63)
    M.P.H., Chief Legal Officer & Corp. Sec.
    Comp: $443.57k
  • Ms. Christine Desrochers
    Interim CFO & Corp. Controller
  • Mr. Michael Fillion
    Chief Operating Officer
  • Eric Rickenbach
    Sr. VP of US Sales
  • Mr. Terrance Wong
    Sr. VP of Engineering & Regulatory
  • Ms. Erin Henry (Age 38)
    Corp. Controller
  • Dr. Daniel Steines M.D. (Age 54)
    MS, Consultant

Key Competitors

View All Competitors














CFMS Stock Analysis - Frequently Asked Questions

Should I buy or sell Conformis stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Conformis in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CFMS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CFMS, but not buy additional shares or sell existing shares.
View CFMS analyst ratings or view top-rated stocks.

How were Conformis' earnings last quarter?

Conformis, Inc. (NASDAQ:CFMS) released its earnings results on Wednesday, November, 3rd. The medical instruments supplier reported ($1.75) earnings per share for the quarter, hitting analysts' consensus estimates of ($1.75). The medical instruments supplier earned $14.25 million during the quarter, compared to analyst estimates of $14.08 million. Conformis had a negative trailing twelve-month return on equity of 86.46% and a negative net margin of 72.72%. During the same quarter in the previous year, the company earned ($2.25) EPS.

When did Conformis' stock split?

Conformis's stock reverse split on the morning of Wednesday, November 9th 2022. The 1-25 reverse split was announced on Wednesday, November 9th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, November 9th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

What is Mark Augusti's approval rating as Conformis' CEO?

15 employees have rated Conformis Chief Executive Officer Mark Augusti on Glassdoor.com. Mark Augusti has an approval rating of 55% among the company's employees. This puts Mark Augusti in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Conformis own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Conformis investors own include Advanced Micro Devices (AMD), Martin Midstream Partners (MMLP), Micron Technology (MU), NVIDIA (NVDA), Trevena (TRVN), Cisco Systems (CSCO), Pfizer (PFE), AbbVie (ABBV), Alibaba Group (BABA) and AT&T (T).

When did Conformis IPO?

(CFMS) raised $135 million in an IPO on Wednesday, July 1st 2015. The company issued 9,000,000 shares at $14.00-$16.00 per share. J.P. Morgan and Deutsche Bank Securities acted as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

Who are Conformis' major shareholders?

Conformis' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include J Brent Alldredge, Kenneth P Fallon III, Mark A Augusti, Mark A Augusti and Robert S Howe.
View institutional ownership trends.

This page (NASDAQ:CFMS) was last updated on 12/3/2023 by MarketBeat.com Staff

My Account -